Evidence map›Paper›PMID 36781487›Full record

ArticleArchives of microbiology2023

Nonomuraea sediminis sp. nov., a novel actinobacterium with antimicrobial activity, isolated from sediment of Dianchi Lake.

Chaolan Liu, Ao Zhu, Jiabei Hou, Limei Wang, Ruilin Zhang, Jianghua Li, Yidong Guo, Yiwen Chu

Abstract read
PubMed Publisher
In one paragraph

Article in Archives of microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Chaolan LiuAntibiotics Research and Re-evaluation Key Laboratory of Sichuan Province, School of Pharmacy, Chengdu University, Chengdu, 610106, People's Republic of China. liuchaolan@cdu.edu.cn.
Ao ZhuAntibiotics Research and Re-evaluation Key Laboratory of Sichuan Province, School of Pharmacy, Chengdu University, Chengdu, 610106, People's Republic of China.
Jiabei HouAntibiotics Research and Re-evaluation Key Laboratory of Sichuan Province, School of Pharmacy, Chengdu University, Chengdu, 610106, People's Republic of China.
Limei WangAntibiotics Research and Re-evaluation Key Laboratory of Sichuan Province, School of Pharmacy, Chengdu University, Chengdu, 610106, People's Republic of China.
Ruilin ZhangAntibiotics Research and Re-evaluation Key Laboratory of Sichuan Province, School of Pharmacy, Chengdu University, Chengdu, 610106, People's Republic of China.
Jianghua LiAntibiotics Research and Re-evaluation Key Laboratory of Sichuan Province, School of Pharmacy, Chengdu University, Chengdu, 610106, People's Republic of China.
Yidong GuoAntibiotics Research and Re-evaluation Key Laboratory of Sichuan Province, School of Pharmacy, Chengdu University, Chengdu, 610106, People's Republic of China.
Yiwen ChuAntibiotics Research and Re-evaluation Key Laboratory of Sichuan Province, School of Pharmacy, Chengdu University, Chengdu, 610106, People's Republic of China.

Funding

Natural Science Foundation of Sichuan Province No.2022NSFSC0591Sichuan Science and Technology Program No. 2020YJ0276
6 · The paper itself

Abstract

A novel actinobacterium with antimicrobial activity, designated strain H16431

Indexed as

ActinomycetalesAnti-Infective AgentsBacterial Typing TechniquesChinaDiaminopimelic AcidDNA, BacterialFatty AcidsLakesPhosphatidylethanolaminesPhospholipidsPhylogenyRNA, Ribosomal, 16SSequence Analysis, DNASoil MicrobiologyVitamin K 2Anti-Infective AgentsDiaminopimelic AcidDNA, BacterialFatty AcidsPhosphatidylethanolaminesPhospholipidsRNA, Ribosomal, 16SVitamin K 2Antimicrobial activityGenome featuresNonomuraea sediminis sp. nov.Polyphasic taxonomy

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.